Stockholm, January 16, 2025 - Intervacc AB (publ) has received orders from Dechra Pharmaceuticals with a total order value equivalent to approximately SEK 5.8 million. Orders received relate to Strangvac, a vaccine against the highly contagious and serious infectious disease strangles that affects horses. The order value relates …
